Maximus, Inc. (MMS) benefits from its strong relationship with governments, allowing the company to generate recurring revenues from long-term contracts. MMS' strong cash flow and ability to borrow a hefty credit to meet working capital requirements provide a competitive edge. However, it is witnessing declining net income due to rising operating expenses and non-recurring costs. MMS reported impressive third-quarter fiscal 2024 results. Quarterly adjusted earnings of $1.7 per share beat the Zacks Consensus ...

It has been about a month since the last earnings report for Maximus (MMS) . Shares have added about 2.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Maximus due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Maximus Beats Q3 Earnings Estimates Maximus reported ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are ...

Maximus, Inc. (MMS) reported impressive third-quarter fiscal 2024 results, with earnings and revenues surpassing the Zacks Consensus Estimate. Quarterly adjusted earnings of $1.7 per share beat the Zacks Consensus Estimate by 18.4% and increased more than 100% on a year-over-year basis. Revenues of $1.3 billion beat the consensus mark by 3% and rose 10.6% from the year-ago quarter. Segmental Revenues The U.S. Federal Services segment's revenues of $683.3 million rose 17% from the year-ago reported number an ...

| --- | --- | |--------------------------------------|-------| | | | | | | | | | | | | | Fiscal 2024 | | | Third Quarter | | | Earnings Call | | | David Mutryn Chief Financial Officer | | | August 8, 2024 | | Forward-looking Statements & Non-GAAP Information These slides should be read in conjunction with our most recent quarterly earnings press release, along with listening to or reading a transcript of management comments from our most recent quarterly earnings conference call. This document may contain n ...

For the quarter ended June 2024, Maximus (MMS) reported revenue of $1.31 billion, up 10.6% over the same period last year. EPS came in at $1.74, compared to $0.78 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.28 billion, representing a surprise of +3.02%. The company delivered an EPS surprise of +18.37%, with the consensus EPS estimate being $1.47. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...

Maximus (MMS) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 18.37%. A quarter ago, it was expected that this government health services provider would post earnings of $1.31 per share when it actually produced earnings of $1.57, delivering a surprise of 19.85%. Over the last four qu ...

Wall Street analysts forecast that Maximus (MMS) will report quarterly earnings of $1.47 per share in its upcoming release, pointing to a year-over-year increase of 88.5%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 7.4% compared to the year-ago quarter. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ...

Maximus, Inc. (MMS) shares have had an impressive run in the past three months. The stock has rallied 11% compared with the 7% growth of its industry and the 8.8% increase of the Zacks S&P 500 composite. This rally aligns with the performance of its closest competitors, Booz Allen Hamilton (BAH) , which has risen 7%, and Accenture (ACN) , which has rallied 4% over the same period. Zacks Investment Research Image Source: 3 Months Price Performance The stock closed at $89.98 in its last trading session, close ...

Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks. In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with ...